Three core pathways guide diagnosis in suspected kidney disease: a blood test for serum creatinine that calculates your estimated glomerular filtration rate (eGFR), a urine test measuring the albumin-to-creatinine ratio (ACR), and imaging such as ultrasound when structural problems are suspected. Most early kidney damage produces no symptoms at all, which is exactly why a routine lab panel catches what daily life cannot. By the time swelling, fatigue, or foamy urine appear, function may already have dropped significantly.
Below is a step-by-step walkthrough of how the diagnostic process works, from a first screening through follow-up imaging, so you know what each test measures and what the numbers mean for your situation.
Why Kidney Disease Often Goes Undetected Without Testing
Kidneys can lose up to 90% of their filtering capacity before any symptom reaches daily awareness. The organ is built with so much reserve that fatigue, swollen ankles, or changes in urination tend to arrive late, not early. By then, the medical term chronic kidney disease (CKD) often applies, a slow, progressive loss of function that develops over months and years rather than days.
This silent pattern contrasts sharply with acute kidney injury (AKI), a sudden drop in function usually triggered by dehydration, a severe infection, or certain medications. AKI announces itself through rapidly dropping urine output, confusion, or fluid overload, and it shows up clearly on the same blood and urine panels. CKD hides precisely because the decline is gradual enough that the body adapts.
Routine screening matters even when you feel completely healthy. A single creatinine blood draw paired with a urine sample provides a baseline that catches small drifts over time. Without that baseline, doctors have nothing to compare against, and slow changes get missed until they become harder to manage.
A single abnormal reading can look alarming, but it takes the right tests to know what that number actually means.
The Core Tests Doctors Use To Evaluate Kidney Function
Two lab tests form the backbone of kidney disease screening: a blood test measuring creatinine and a urine test measuring albumin. Imaging adds structural detail when those labs raise questions.
Serum Creatinine and the eGFR Calculation
Creatinine is a waste product generated whenever your muscles contract. Healthy kidneys filter it out of the blood and excrete it through urine. A serum creatinine blood test measures how much of this waste sits in your bloodstream. When creatinine climbs, it usually means the kidneys are filtering less effectively than they should.
Doctors plug that creatinine number into a formula, along with your age, sex, and sometimes race, to calculate the estimated glomerular filtration rate (eGFR). The eGFR estimates how many milliliters of blood your kidneys filter per minute, and it has become the single most useful indicator of kidney function in everyday medicine.
Urine Albumin-to-Creatinine Ratio (ACR)
This laboratory test quantifies how much albumin, a type of protein, leaks into your urine relative to creatinine. A healthy kidney holds albumin back in the bloodstream. When albumin shows up in urine (a condition called albuminuria or proteinuria), it signals that the kidney’s filtering barrier has been damaged.
A first-morning urine sample gives the most accurate read, because exercise, dehydration, and a high-protein meal can briefly push protein levels up and skew results. Doctors often repeat an abnormal ACR within three months before diagnosing persistent proteinuria.
Blood Urea Nitrogen and Basic Urinalysis
Urea, a waste product formed when the liver breaks down protein, is what blood urea nitrogen (BUN) measures in the bloodstream. BUN rises when kidneys slow down, but it also rises with dehydration, a high-protein diet, or gastrointestinal bleeding, so it is interpreted alongside creatinine rather than alone. A BUN-to-creatinine ratio helps doctors tell kidney trouble apart from simple dehydration.
A basic urinalysis rounds out the initial screen. That dipstick test checks urine for protein, blood, glucose, signs of infection, and microscopic elements like casts or crystals. Abnormal findings prompt deeper investigation, while a clean dipstick makes significant kidney disease less likely.
Understanding eGFR, Creatinine, BUN, and ACR Results
Numbers on a lab report mean very little until you understand what range they fall into and what each range implies for kidney function.
Reading eGFR Ranges
An eGFR of 90 or higher is generally considered normal, though a value right at 90 with other warning signs may still warrant attention. An eGFR between 60 and 89 suggests mildly reduced function, often labeled stage 2 CKD when other markers are also abnormal. Values from 30 to 59 cover stages 3a and 3b, where complications like anemia or bone disease start to surface.
Below 30 (stages 4 and 5) signals advanced disease, and below 15 typically points toward kidney failure requiring dialysis or transplant planning.
What Elevated Creatinine Means
Creatinine varies widely between people, because muscle mass drives its production. A bodybuilder may have a creatinine of 1.3 mg/dL and be perfectly healthy, while a small, older woman with the same number may have meaningfully reduced kidney function. Diet matters too: a large steak the night before a blood draw can nudge creatinine up.
Hydration status and certain medications (including some antibiotics and heartburn drugs) also shift the number, which is why doctors interpret creatinine in context, never in isolation.
Decoding ACR Thresholds
An ACR below 30 mg/g is generally considered normal. A value from 30 to 300 signals microalbuminuria, an early sign of kidney damage common in diabetes and hypertension. Anything above 300 indicates macroalbuminuria, or overt proteinuria, which carries a higher risk of kidney disease progression and cardiovascular events.
Doctors read these values together rather than in isolation. A normal eGFR alongside an elevated ACR still signals kidney damage, and an abnormal eGFR with normal ACR can suggest causes unrelated to filtration injury, such as obstruction or low muscle mass.
Knowing your risk shapes how often these results actually warrant a closer look.
| Test | What It Measures | Normal Range (Approximate) | Abnormal Reading Suggests |
|---|---|---|---|
| eGFR | Filtering capacity | 90+ mL/min/1.73m² | Reduced kidney function |
| Serum Creatinine | Muscle waste in blood | 0.6–1.3 mg/dL (varies) | Possible filtration decline |
| BUN | Urea nitrogen in blood | 7–20 mg/dL | Dehydration or kidney trouble |
| ACR | Protein leak in urine | Below 30 mg/g | Glomerular damage |
When To Get Tested and Who Faces Higher Risk
The National Kidney Foundation recommends that healthy adults at average risk get kidney function tested at least every three years. A standard metabolic panel or comprehensive metabolic panel, often part of an annual physical, typically includes creatinine and BUN.
Higher-Risk Groups Needing More Frequent Testing
Several conditions raise your odds of kidney disease and warrant yearly or even more frequent screening:
- Diabetes: High blood sugar damages the glomeruli over time. Diabetic kidney disease is the leading cause of kidney failure in the United States.
- Hypertension: Elevated pressure injures the small blood vessels that feed the nephrons.
- Family history: A close relative with kidney disease or kidney failure increases genetic and shared-environment risk.
- Obesity: Excess weight drives both diabetes and hypertension, compounding kidney stress.
- Recurring urinary tract issues: Chronic obstruction, stones, or infections scar kidney tissue.
- Cardiovascular disease: Heart and kidney function are tightly linked; one failing often strains the other.
Testing frequency typically increases once any abnormality appears. After an abnormal eGFR or ACR, doctors often repeat the labs within three months to confirm persistence, then monitor every three to twelve months depending on the stage.
Confirming a problem is just the start, since figuring out its cause often requires looking directly at the kidneys.
Imaging, Biopsy, and Other Follow-Up Tests
Lab tests tell you how well the kidneys are working. Imaging and, in rarer cases, biopsy tell you why they may be failing.
Ultrasound, CT, and MRI
A kidney ultrasound is usually the first imaging step. Sound waves paint a picture of kidney size, shape, and position, and can reveal cysts, stones, tumors, or blockages. Ultrasound is quick, painless, and uses no radiation, which is why it is often the first choice when labs are abnormal or symptoms suggest obstruction.
CT or MRI scans come next when doctors need sharper detail, particularly for vascular problems, complex cysts, or suspected masses. A CT angiogram, for instance, can map the renal arteries to look for narrowing that drives high blood pressure and kidney damage.
Kidney Biopsy
Using a needle to extract a tiny piece of kidney tissue, this procedure lets a pathologist examine the sample under a microscope. It is reserved for unexplained kidney dysfunction, suspected glomerular disease (such as IgA nephropathy or focal segmental glomerulosclerosis), or unclear causes of nephrotic syndrome. The procedure carries small risks, including bleeding, so it is used only when the result will change treatment.
Home and Mail-In Kidney Screening
Direct-to-consumer kidney test kits have grown more common. Some test urine albumin using a home dipstick; others require a mailed-in blood spot. The CDC and NIH note these can flag early abnormalities but should be confirmed with a clinical lab and interpreted by a clinician. A home screening result is a starting point, not a diagnosis.
| Follow-Up Test | Primary Use | Typical Setting |
|---|---|---|
| Kidney ultrasound | Size, cysts, stones, blockages | Outpatient radiology |
| CT or MRI | Vascular or structural detail | Specialized imaging center |
| Kidney biopsy | Tissue diagnosis for unclear dysfunction | Hospital or specialty clinic |
| Home urine dipstick | Initial albumin or blood check | At home |
| Mail-in blood spot | Creatinine-based eGFR estimate | Direct-to-consumer kit |
Preparing for a Kidney Function Test and Acting on the Results
Most kidney function tests require little preparation, though a few details can sharpen the result.
What To Expect During the Blood Draw and Urine Collection
Blood work for creatinine and BUN does not usually require fasting, but many doctors bundle it into a fasting metabolic panel, so check ahead. The draw itself takes under five minutes. For the urine ACR, a first-morning sample is ideal, because it concentrates the urine and reduces false positives from exercise or diet.
Drink a normal amount of water the day before. Overhydration dilutes the urine and can push ACR readings lower than they really are.
Bring a list of every medication and supplement you take. Common drugs, including ACE inhibitors, NSAIDs, and some antibiotics, shift creatinine and protein readings. Mentioning them helps the clinician interpret the numbers correctly.
Questions To Bring to Your Appointment
- Panel differences: A basic metabolic panel covers creatinine and BUN; a comprehensive panel adds liver enzymes and proteins.
- Why urine matters: Adding it catches early glomerular damage that blood work alone can miss.
- Screening cadence: Annual screening suits most healthy adults; higher-risk groups need more frequent checks.
- Specialist triggers: Persistent abnormalities or an eGFR below 60 usually warrant specialist input.
Understanding the KDIGO Five-Stage Framework
The Kidney Disease: Improving Global Outcomes (KDIGO) framework classifies CKD using both GFR and albuminuria categories. GFR stages run from G1 (normal) to G5 (kidney failure). Albuminuria categories run from A1 (normal to mildly increased) to A3 (severely increased). Combining the two creates a risk grid that guides monitoring cadence and specialist referrals.
Next Steps After an Abnormal Result
Work with your doctor to repeat the test, since one abnormal reading does not diagnose CKD. Confirm blood pressure control, blood sugar management, and any medication adjustments. Lifestyle factors such as sodium reduction, regular physical activity, and smoking cessation help preserve kidney function over time. If results remain abnormal or worsen, a nephrologist can map out a longer monitoring plan.
If eGFR sits below 30 or proteinuria is heavy, ask about referral to a nephrologist. Specialist involvement earlier in advanced stages improves long-term outcomes.
Final Takeaways
Kidney disease stays invisible until labs reveal it, which is why routine screening every three years, and more often for higher-risk groups, makes the difference between catching damage early and learning about it late. Blood creatinine, urine albumin, and imaging together form the diagnostic backbone that turns silent decline into something you and your doctor can act on.
FAQ
What tests are used to diagnose kidney disease?
A serum creatinine blood test (used to calculate eGFR) and a urine albumin-to-creatinine ratio are the core screening tools. Imaging such as ultrasound, and occasionally a biopsy, follows when those labs are abnormal or the cause is unclear.
How often should you get tested for kidney disease?
Healthy adults at average risk should have kidney function checked at least every three years, per National Kidney Foundation guidance. Higher-risk individuals, including those with diabetes, hypertension, or a family history, typically need annual screening.
What is a normal eGFR level?
An eGFR of 90 mL/min/1.73m² or higher is generally normal, though values between 60 and 89 may still be appropriate depending on age and other markers. A persistent value below 60 suggests chronic kidney disease.
Can kidney disease be detected through a urine test?
Yes. A urine albumin-to-creatinine ratio (ACR) detects protein leakage from damaged glomeruli, often before blood creatinine changes. It is one of the earliest signs of kidney injury, especially in diabetes and hypertension.
Who should be screened for kidney disease?
Diabetes, hypertension, obesity, cardiovascular disease, a family history of kidney failure, or recurrent urinary tract issues all place someone in a higher-risk group that warrants regular screening. Older adults and people on long-term NSAIDs also benefit from routine testing.
What do the stages of chronic kidney disease mean?
The KDIGO framework divides CKD into five stages based on GFR (G1 normal through G5 kidney failure) and three albuminuria categories (A1 mild to A3 severe). Combining the two creates a risk grid that guides how often you are monitored and when a nephrologist gets involved.
